SCHEMBL6276273

SCHEMBL6276273

CC=COc1c(O)c2c(OCCC(=O)O)cccc2oc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ EDNRA P25101 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TDP1 Q9NUW8 2/20 0.33
▸ GPR35 Q9HC97 1/20 0.33
▸ CYP2A6 P11509 1/20 0.32
▸ NMT2 O60551 4/20 0.32
▸ NMT1 P30419 4/20 0.32
▸ BCHE P06276 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ ADRB2 P07550 2/20 0.31
▸ ADRB1 P08588 2/20 0.31
▸ ADRB3 P13945 2/20 0.31
▸ CREB1 P16220 1/20 0.31
▸ MAOB P27338 1/20 0.31
▸ ABCG2 Q9UNQ0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6276271 1.00 NQO1 (0.41) NQO1LMNAALDH1A1SMN1; SMN2EDNRA
SCHEMBL6272720 0.89 NQO1 (0.43) NQO1LMNAALDH1A1SMN1; SMN2EDNRA
SCHEMBL6272721 0.89 NQO1 (0.43) NQO1LMNAALDH1A1SMN1; SMN2EDNRA
SCHEMBL6271675 0.88 NQO1 (0.43) NQO1ALDH1A1EDNRATDP1CYP2A6
SCHEMBL6271677 0.88 NQO1 (0.43) NQO1ALDH1A1EDNRATDP1CYP2A6
SCHEMBL6276208 0.87 NQO1 (0.43) NQO1TDP1CYP2A6NMT2NMT1
SCHEMBL6276215 0.87 NQO1 (0.43) NQO1TDP1CYP2A6NMT2NMT1
SCHEMBL6276942 0.85 LMNA (0.51) NQO1LMNAALDH1A1EDNRAALOX15
SCHEMBL6272674 0.84 EPHX2 (0.39) NQO1ALDH1A1KDM4E
SCHEMBL6272666 0.84 EPHX2 (0.39) NQO1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 NQO1 1320/4885LMNA 4503/4885ALDH1A1 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback